Kuo Yuyun Tristan 4
4 · China Biologic Products, Inc. · Filed Dec 14, 2011
Insider Transaction Report
Form 4
Kuo Yuyun Tristan
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2011-12-13$4.00/sh+20,000$80,000→ 20,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2011-12-13−20,000→ 115,000 totalExercise: $4.00From: 2008-06-01Exp: 2018-06-01→ Common Stock (20,000 underlying) - Exercise/Conversion
Common Stock
2011-12-14$4.00/sh+5,000$20,000→ 5,000 total - Exercise/Conversion
Common Stock
2011-12-12$4.00/sh+25,000$100,000→ 25,000 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2011-12-12−25,000→ 135,000 totalExercise: $4.00From: 2008-06-01Exp: 2018-06-01→ Common Stock (25,000 underlying) - Sale
Common Stock
2011-12-12$11.34/sh−25,000$283,500→ 0 total - Sale
Common Stock
2011-12-13$11.69/sh−20,000$233,850→ 0 total - Sale
Common Stock
2011-12-14$11.60/sh−5,000$58,000→ 0 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2011-12-14−5,000→ 110,000 totalExercise: $4.00From: 2008-06-01Exp: 2018-06-01→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]Reflects previously reported stock options to purchase an aggregate of 160,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan.